Finding a certain link between inflammatory genetic markers and IHD requires a number of well-designed studies of phenotypically homogeneous subjects as well as multiple analyses of gene–gene and gene–environment interactions.[57] According to our study, it is believable that TNF-α −308G/A gene polymorphism might be a suitable genetic marker for IHD risk. This evidence concerns the gene TNF and myocardial ischemia.